ArticleNature metabolism2020

The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer.

Jiyeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.